238 related articles for article (PubMed ID: 23657896)
1. A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.
Encinas E; Calvo R; Lukas JC; Vozmediano V; Rodriguez M; Suarez E
Paediatr Drugs; 2013 Jun; 15(3):247-57. PubMed ID: 23657896
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion versus intermittent bolus doses of fentanyl for analgesia and sedation in neonates: an open-label randomised controlled trial.
Abiramalatha T; Mathew SK; Mathew BS; Shabeer MP; Arulappan G; Kumar M; Jayaseelan V; Kuruvilla KA
Arch Dis Child Fetal Neonatal Ed; 2019 Jul; 104(4):F433-F439. PubMed ID: 30322973
[TBL] [Abstract][Full Text] [Related]
3. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic model of subcutaneous fentanyl in older acute care patients.
Al-Qurain AA; Upton R; Williams DB; Mackenzie L; Phillips C; Russell PT; Tadros R; Roberts MS; Wiese MD
Eur J Clin Pharmacol; 2021 Sep; 77(9):1357-1368. PubMed ID: 33811491
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients.
Frenkel C; Schuttler J; Ihmsen H; Heye H; Rommelsheim K
Intensive Care Med; 1995 Dec; 21(12):981-8. PubMed ID: 8750122
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
Scholz J; Steinfath M; Schulz M
Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgery - a study of pharmacodynamic drug-drug interactions.
Wiczling P; Bieda K; Przybyłowski K; Hartmann-Sobczyńska R; Borsuk A; Matysiak J; Kokot ZJ; Sobczyński P; Grześkowiak E; Bienert A
Biopharm Drug Dispos; 2016 Jul; 37(5):252-63. PubMed ID: 26990035
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics.
Yassen A; Olofsen E; Dahan A; Danhof M
J Pharmacol Exp Ther; 2005 Jun; 313(3):1136-49. PubMed ID: 15701707
[TBL] [Abstract][Full Text] [Related]
11. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children.
Lim SY; Miller JL; Henry E; Heltsley R; Woo S; Johnson PN
Pharmacotherapy; 2021 Apr; 41(4):359-369. PubMed ID: 33604895
[TBL] [Abstract][Full Text] [Related]
12. Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling.
Shum S; Shen DD; Isoherranen N
Drug Metab Dispos; 2021 Nov; 49(11):1003-1015. PubMed ID: 34407992
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects and pharmacokinetic profile of continuous infusion fentanyl in newborn piglets.
Rajan V; Beharry KD; Williams P; Modanlou HD
Biol Neonate; 1998; 74(1):39-47. PubMed ID: 9657668
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.
Ziesenitz VC; Vaughns JD; Koch G; Mikus G; van den Anker JN
Clin Pharmacokinet; 2018 Feb; 57(2):125-149. PubMed ID: 28688027
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic meta-analysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain.
Kaessner N; Nave R; Roepcke S; Facius A; Lahu G
Int J Clin Pharmacol Ther; 2012 Sep; 50(9):665-77. PubMed ID: 22784611
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
Foster D; Upton R; Christrup L; Popper L
Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
[TBL] [Abstract][Full Text] [Related]
17. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
18. Opioid pharmacodynamics in neonatal dogs: differences between morphine and fentanyl.
Bragg P; Zwass MS; Lau M; Fisher DM
J Appl Physiol (1985); 1995 Nov; 79(5):1519-24. PubMed ID: 8594008
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children.
Ward RM; Drover DR; Hammer GB; Stemland CJ; Kern S; Tristani-Firouzi M; Lugo RA; Satterfield K; Anderson BJ
Paediatr Anaesth; 2014 Jun; 24(6):591-601. PubMed ID: 24666686
[TBL] [Abstract][Full Text] [Related]
20. Optimizing intraoperative administration of propofol, remifentanil, and fentanyl through pharmacokinetic and pharmacodynamic simulations to increase the postoperative duration of analgesia.
Tams C; Syroid N; Vasilopoulos T; Johnson K
J Clin Monit Comput; 2019 Dec; 33(6):959-971. PubMed ID: 30864076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]